According to a new study, a simple physician counseling process during usual care visits is effective in encouraging sedentary overweight or obese patients with type 2 diabetes to have a healthier lifestyle. “Patients reported that support from their physician was the most important component of the intervention.”
Read More »Diabetes In Control
Caffeine Boosts Blood Sugar Among Patients with Diabetes
Caffeine in even moderate doses may impair glucose control in type 2 diabetes, researchers report. Consuming equivalent of 4 cups a day led to spikes in blood sugar levels of 8%.
Read More »FDA Issues Early Communication about an Ongoing Review of Vytorin
The U.S. Food and Drug Administration today issued an Early Communication regarding the agency’s ongoing review of Vytorin based on preliminary results from a recently completed study.
Read More »Does L-Arginine Supplementation Make A Difference?
Researchers have found that diabetes creates too much competition for an amino acid called L-arginine that helps blood vessels to relax.
Read More »Novartis Gets E.U. Approval For Diabetes Drug Galvus
European authorities have approved Novartis’s drug Galvus (vildagliptin), a DPP-4 inhibitor, as a new oral treatment for type 2 diabetes patients.
Read More »Single Tool Predicts Specific Cardiovascular Risks
A patient’s global cardiovascular disease risk can be predicted accurately by an office-friendly algorithm, according to investigators.
Read More »Testosterone Reduces Visceral Fat Gain in Nonobese Older Men
Researchers report, that testosterone therapy lessens the gain in visceral adipose tissue and the loss of skeletal muscle in aging men who are not obese.
Read More »Consequences of a Burger, Fries, and A Diet Soda
Middle-age adults who regularly eat a double burger, fries, and a diet soda for lunch or dinner increase their risk of incident metabolic syndrome by 25% compared with those who limit red meat to two servings a week.
Read More »Diuretics Comparable or Better Than Other Drugs for Hypertension
Use of calcium-channel blockers, alpha-blockers or angiotensin-converting enzyme (ACE) inhibitors appears to offer no advantages in improving clinical outcomes compared with use of diuretics when treating hypertension among individuals with metabolic syndrome. Even more so for black patients.
Read More »Bra Size May Predict Type 2 Diabetes Risk in Later Life
A new study suggests that, a woman’s bra size at age 20 may predict her risk of developing Type 2 diabetes later in life, with larger cup size linked to higher rates of diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.